目次

TABLE OF CONTENTS

1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key sources for secondary data
2.1.1.2 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key primary sources
2.1.2.2 Key objectives of primary research
2.1.2.3 Key data from primary sources
2.1.2.4 Key industry insights
2.1.2.5 Breakdown of primaries
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Company revenue estimation approach
2.2.1.1.1 Presentations of companies and primary interviews
2.2.1.1.2 Primary interviews
2.2.2 TOP-DOWN APPROACH
2.3 DATA TRIANGULATION
2.4 MARKET SHARE ANALYSIS
2.5 STUDY ASSUMPTIONS
2.5.1 PARAMETRIC ASSUMPTIONS
2.5.2 GROWTH RATE ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.6.1 METHODOLOGY-RELATED LIMITATIONS
2.6.2 SCOPE-RELATED LIMITATIONS
2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS
4.1 PATIENT TEMPERATURE MONITORING MARKET OVERVIEW
4.2 ASIA PACIFIC: PATIENT TEMPERATURE MONITORING MARKET, BY PRODUCT AND COUNTRY
4.3 PATIENT TEMPERATURE MONITORING MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
4.4 PATIENT TEMPERATURE MONITORING MARKET: REGIONAL MIX, 2025 VS. 2032
4.5 PATIENT TEMPERATURE MONITORING MARKET: EMERGING VS. DEVELOPED ECONOMIES

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing prevalence of infectious diseases
5.2.1.2 Growing awareness about continuous temperature monitoring for surgical patients
5.2.1.3 Rising volume of surgical interventions
5.2.1.4 Increased adoption of remote patient monitoring in home healthcare settings
5.2.2 RESTRAINTS
5.2.2.1 Elevated costs of advanced temperature monitoring systems in emerging economies
5.2.2.2 Risks associated with invasive temperature monitoring devices
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing growth opportunities in emerging markets
5.2.3.2 Increased focus on better healthcare infrastructure and digital health initiatives in emerging economies
5.2.3.3 Integration of predictive analytics in vital sign monitoring systems
5.2.3.4 Rising need for blood transfusions among chronic patients
5.2.4 CHALLENGES
5.2.4.1 Limited accuracy and reliability in infrared and traditional mercury thermometers
5.2.4.2 Incorporation of inorganic growth strategies among key players
5.3 TECHNOLOGY ANALYSIS
5.3.1 KEY TECHNOLOGIES
5.3.1.1 Sensor technologies
5.3.1.2 Digital thermometry and wearables
5.3.2 COMPLEMENTARY TECHNOLOGIES
5.3.2.1 Electronic health records
5.3.2.2 Remote patient monitoring platforms
5.3.3 ADJACENT TECHNOLOGIES
5.3.3.1 Multi-parameter wearable biosensors
5.4 PORTER'S FIVE FORCES ANALYSIS
5.4.1 BARGAINING POWER OF BUYERS
5.4.2 BARGAINING POWER OF SUPPLIERS
5.4.3 THREAT OF NEW ENTRANTS
5.4.4 THREAT OF SUBSTITUTES
5.4.5 INTENSITY OF COMPETITIVE RIVALRY
5.5 KEY STAKEHOLDERS & BUYING CRITERIA
5.5.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.5.2 KEY BUYING CRITERIA
5.6 REGULATORY ANALYSIS
5.6.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.6.2 REGULATORY FRAMEWORK
5.6.2.1 North America
5.6.2.1.1 US
5.6.2.1.2 Canada
5.6.2.2 Europe
5.6.2.3 Asia Pacific
5.6.2.3.1 China
5.6.2.3.2 Japan
5.6.2.3.3 India
5.6.2.4 Latin America
5.6.2.4.1 Brazil
5.6.2.4.2 Mexico
5.6.2.5 Middle East
5.6.2.6 Africa
5.7 PATENT ANALYSIS
5.7.1 LIST OF MAJOR PATENTS
5.8 TRADE ANALYSIS
5.8.1 IMPORT DATA FOR HS CODE 902511, 2020-2024
5.8.2 EXPORT DATA FOR HS CODE 902511, 2020-2024
5.9 PRICING ANALYSIS
5.9.1 AVERAGE SELLING PRICE TREND OF PATIENT TEMPERATURE MONITORING DEVICES, BY KEY PLAYER, 2022-2024
5.9.2 AVERAGE SELLING PRICE TREND OF PATIENT TEMPERATURE MONITORING DEVICES, BY REGION, 2022-2024
5.10 REIMBURSEMENT ANALYSIS
5.10.1 NORTH AMERICA
5.10.1.1 US
5.10.1.1.1 Medicare reimbursement for remote patient monitoring
5.10.2 EUROPE
5.10.3 ASIA PACIFIC
5.10.4 GLOBAL CONSIDERATIONS
5.11 KEY CONFERENCES & EVENTS, 2025-2026
5.12 UNMET NEEDS/END-USER EXPECTATIONS
5.13 VALUE CHAIN ANALYSIS
5.14 SUPPLY CHAIN ANALYSIS
5.15 IMPACT OF AI/GEN AI ON PATIENT TEMPERATURE MONITORING MARKET
5.15.1 MARKET POTENTIAL OF AI/GEN AI
5.15.2 KEY AI USE CASES
5.15.3 FUTURE OF AI/GEN AI
5.16 IMPACT OF 2025 US TARIFF REGULATION ON PATIENT TEMPERATURE MONITORING MARKET
5.16.1 INTRODUCTION
5.16.2 KEY TARIFF RATES
5.16.3 PRICE IMPACT ANALYSIS
5.16.4 KEY IMPACTS ON COUNTRY/REGION
5.16.4.1 North America
5.16.4.1.1 US
5.16.4.2 Europe
5.16.4.3 Asia Pacific
5.16.5 IMPACT ON END-USE INDUSTRIES
5.16.5.1 Hospitals
5.16.5.2 Ambulatory care centers
5.17 ECOSYSTEM ANALYSIS
5.17.1 ROLE IN ECOSYSTEM
5.18 CASE STUDY ANALYSIS
5.18.1 ESVYDA'S REMOTE PATIENT MONITORING SYSTEM TO ENHANCE CHRONIC CARE THROUGH TEMPERATURE AND VITAL SIGN TRACKING
5.19 ADJACENT MARKET ANALYSIS
5.20 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
5.21 INVESTMENT & FUNDING SCENARIO

6 PATIENT TEMPERATURE MONITORING MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 WEARABLE CONTINUOUS MONITORING SENSORS
6.2.1 INCREASED PREFERENCE FOR PORTABLE TEMPERATURE MONITORING DEVICES TO AID MARKET GROWTH
6.3 SMART TEMPERATURE MONITORING PATCHES
6.3.1 NEED FOR CONTINUOUS HEALTH STATUS MONITORING OF INFANTS, ELDERLY, AND POST-OPERATIVE PATIENTS TO DRIVE MARKET
6.4 TABLETOP TEMPERATURE MONITORING DEVICES
6.4.1 NON-INVASIVE VITAL SIGNS MONITORING DEVICES
6.4.1.1 High demand for automatic, rapid, and routine measurement and documentation of vital signs to aid adoption in hospital settings
6.4.2 CONTINUOUS CORE BODY TEMPERATURE MONITORING DEVICES
6.4.2.1 Increasing incidence of cardiac arrest, head injury, and stroke to propel need for core body temperature monitoring
6.5 HANDHELD TEMPERATURE MONITORING DEVICES
6.5.1 DIGITAL THERMOMETERS
6.5.1.1 Better accuracy, easy portability, and improved user interface to spur segment growth
6.5.2 INFRARED THERMOMETERS
6.5.2.1 Faster response time for surface temperature and minimal risk of contamination to aid adoption in infection-sensitive cases
6.5.3 MERCURY THERMOMETERS
6.5.3.1 Lack of accuracy, high maintenance, and slow response time to limit market adoption
6.6 INVASIVE TEMPERATURE MONITORING DEVICES
6.6.1 RISING PREVALENCE OF BLOODSTREAM INFECTIONS TO RESTRICT ADOPTION

7 PATIENT TEMPERATURE MONITORING MARKET, BY SITE
7.1 INTRODUCTION
7.2 NON-INVASIVE TEMPERATURE MONITORING
7.2.1 ORAL TEMPERATURE MONITORING
7.2.1.1 Cost-effectiveness and broad use in general wards to support segment growth
7.2.2 AXILLARY & TEMPORAL ARTERY TEMPERATURE MONITORING
7.2.2.1 Ease of use, non-invasiveness, and better comfort to drive adoption in pediatric, geriatric, and home care applications
7.2.3 TYMPANIC MEMBRANE TEMPERATURE MONITORING
7.2.3.1 High accuracy in core body temperature measurement to facilitate adoption in ambulatory care settings
7.3 INVASIVE TEMPERATURE MONITORING
7.3.1 ESOPHAGEAL TEMPERATURE MONITORING
7.3.1.1 Higher level of accuracy and lower chances of dislocation to drive adoption among anesthetized patients in ICU settings
7.3.2 NASOPHARYNX TEMPERATURE MONITORING
7.3.2.1 Rising risk of epistaxis and sinusitis to hinder market growth
7.3.3 URINARY BLADDER TEMPERATURE MONITORING
7.3.3.1 Low risk of dislocation of temperature probes to boost market growth
7.3.4 RECTAL TEMPERATURE MONITORING
7.3.4.1 Enhanced core temperature accuracy for neonatal and critical care to fuel segment expansion

8 PATIENT TEMPERATURE MONITORING MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 PYREXIA/FEVER
8.2.1 RISING PREVALENCE OF INFECTIOUS DISEASES AND FEBRILE ILLNESSES TO BOOST SEGMENT GROWTH
8.3 HYPOTHERMIA
8.3.1 INCREASING SURGICAL PROCEDURES TO FUEL NEED FOR BETTER TEMPERATURE MONITORING
8.4 ANESTHESIA
8.4.1 RISING MORTALITY RATE DUE TO MALIGNANT HYPERPYREXIA TO DRIVE MARKET
8.5 BLOOD TRANSFUSION
8.5.1 EMPHASIS ON BLOOD TRANSFUSION SAFETY TO DRIVE ADOPTION OF ADVANCED TEMPERATURE MONITORING DEVICES
8.6 OTHER APPLICATIONS

9 PATIENT TEMPERATURE MONITORING MARKET, BY END USER
9.1 INTRODUCTION
9.2 HOSPITALS
9.2.1 INTENSIVE CARE UNITS
9.2.1.1 Increasing cases of thermoregulation disruption to drive adoption of advanced temperature monitoring devices
9.2.2 OPERATING ROOMS
9.2.2.1 Necessity of managing intraoperative hypothermia to augment segment growth
9.2.3 EMERGENCY ROOMS
9.2.3.1 High patient turnover to accelerate demand for rapid and reliable temperature monitoring
9.3 HOME CARE SETTINGS
9.3.1 RISE IN GLOBAL GERIATRIC AND PEDIATRIC POPULATION TO FUEL MARKET GROWTH
9.4 AMBULATORY CARE CENTERS
9.4.1 EASE OF DIAGNOSIS, RAPID RESULT GENERATION, AND IMMEDIATE PATIENT CARE MANAGEMENT TO AID MARKET GROWTH
9.5 URGENT CARE CENTERS
9.5.1 NEED FOR RAPID CLINICAL ASSESSMENT TO AUGMENT ADOPTION OF ACCURATE TEMPERATURE ASSESSMENT TOOLS
9.6 PRIMARY CENTERS
9.6.1 INTEGRATION OF PATIENT TEMPERATURE MONITORING TO SUPPORT TIMELY DIAGNOSIS AND CARE CONTINUITY
9.7 OTHER END USERS

10 PATIENT TEMPERATURE MONITORING MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
10.2.2 US
10.2.2.1 US to dominate North American patient temperature monitoring market during study period
10.2.3 CANADA
10.2.3.1 Growing incidence of chronic diseases and increasing surgical procedures to drive market demand
10.3 EUROPE
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
10.3.2 GERMANY
10.3.2.1 High demand for temperature monitoring devices for perioperative care to propel market growth
10.3.3 UK
10.3.3.1 Rising interventional chronic procedures among geriatric patients to support market growth
10.3.4 FRANCE
10.3.4.1 Rising chronic diseases among geriatric and pediatric populations to spur market growth
10.3.5 ITALY
10.3.5.1 Increase in per capita health spending and occurrence of health complications among geriatric patients to drive market
10.3.6 SPAIN
10.3.6.1 Healthcare modernization and chronic disease management to aid adoption of patient temperature monitoring devices
10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
10.4.2 CHINA
10.4.2.1 Surge in surgical volume and favorable healthcare reforms to fuel market growth
10.4.3 JAPAN
10.4.3.1 Increasing funds for healthcare infrastructure improvement to fuel market growth
10.4.4 INDIA
10.4.4.1 Developing healthcare infrastructure and increasing C-section surgeries to augment market growth
10.4.5 AUSTRALIA
10.4.5.1 Increased government healthcare investments to support market adoption of advanced patient temperature monitoring devices
10.4.6 SOUTH KOREA
10.4.6.1 High geriatric population to drive demand for advanced patient temperature monitoring solutions for chronic conditions
10.4.7 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
10.5.2 BRAZIL
10.5.2.1 Rising volume of surgeries in tertiary care centers to drive adoption of advanced temperature monitoring devices
10.5.3 MEXICO
10.5.3.1 Favorable government initiatives and integration of digital health technologies to propel market growth
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
10.6.2 GCC COUNTRIES
10.6.2.1 Kingdom of Saudi Arabia
10.6.2.1.1 Rapid healthcare digitization to accelerate market expansion
10.6.2.2 UAE
10.6.2.2.1 Growing medical tourism and technological advancements to augment market growth
10.6.2.3 Rest of GCC Countries
10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT TEMPERATURE MONITORING MARKET
11.3 REVENUE ANALYSIS, 2020-2024
11.4 MARKET SHARE ANALYSIS, 2024
11.5 COMPANY VALUATION & FINANCIAL METRICS
11.5.1 FINANCIAL METRICS
11.5.2 COMPANY VALUATION
11.6 BRAND/PRODUCT COMPARISON
11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
11.7.1 STARS
11.7.2 EMERGING LEADERS
11.7.3 PERVASIVE PLAYERS
11.7.4 PARTICIPANTS
11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
11.7.5.1 Company footprint
11.7.5.2 Region footprint
11.7.5.3 Site footprint
11.7.5.4 Product footprint
11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
11.8.1 PROGRESSIVE COMPANIES
11.8.2 RESPONSIVE COMPANIES
11.8.3 DYNAMIC COMPANIES
11.8.4 STARTING BLOCKS
11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
11.8.5.1 Detailed list of key startup/SME players
11.8.5.2 Competitive benchmarking of key startups/SME players
11.9 R&D ASSESSMENT OF KEY PLAYERS
11.10 COMPETITIVE SCENARIO
11.10.1 PRODUCT APPROVALS
11.10.2 DEALS

12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 KONINKLIJKE PHILIPS N.V.
12.1.1.1 Business overview
12.1.1.2 Products offered
12.1.1.3 Recent developments
12.1.1.3.1 Deals
12.1.1.4 MnM view
12.1.1.4.1 Key strengths
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses & competitive threats
12.1.2 CARDINAL HEALTH
12.1.2.1 Business overview
12.1.2.2 Products offered
12.1.2.3 MnM view
12.1.2.3.1 Key strengths
12.1.2.3.2 Strategic choices
12.1.2.3.3 Weaknesses & competitive threats
12.1.3 BAXTER (HILL-ROM HOLDINGS, INC.)
12.1.3.1 Business overview
12.1.3.2 Products offered
12.1.3.3 MnM view
12.1.3.3.1 Key strengths
12.1.3.3.2 Strategic choices
12.1.3.3.3 Weaknesses & competitive threats
12.1.4 DRAGERWERK AG & CO. KGAA
12.1.4.1 Business overview
12.1.4.2 Products offered
12.1.4.3 MnM view
12.1.4.3.1 Key strengths
12.1.4.3.2 Strategic choices
12.1.4.3.3 Weaknesses & competitive threats
12.1.5 HELEN OF TROY
12.1.5.1 Business overview
12.1.5.2 Products offered
12.1.5.3 MnM view
12.1.5.3.1 Key strengths
12.1.5.3.2 Strategic choices
12.1.5.3.3 Weaknesses & competitive threats
12.1.6 BECTON, DICKINSON AND COMPANY
12.1.6.1 Business overview
12.1.6.2 Products offered
12.1.7 OMRON HEALTHCARE, INC.
12.1.7.1 Business overview
12.1.7.2 Products offered
12.1.8 MASIMO
12.1.8.1 Business overview
12.1.8.2 Products offered
12.1.8.3 Recent developments
12.1.8.3.1 Product approvals
12.1.8.3.2 Deals
12.1.9 SOLVENTUM
12.1.9.1 Business overview
12.1.9.2 Products offered
12.1.9.3 Recent developments
12.1.9.3.1 Deals
12.1.10 TERUMO CORPORATION
12.1.10.1 Business overview
12.1.10.2 Products offered
12.2 OTHER PLAYERS
12.2.1 PAUL HARTMANN AG
12.2.2 BEURER GMBH
12.2.3 MICROLIFE CORPORATION
12.2.4 OMEGA ENGINEERING INC.
12.2.5 IHEALTH LABS INC.
12.2.6 DELTATRAK INC.
12.2.7 EXERGEN
12.2.8 MEDISANA GMBH
12.2.9 GERATHERM MEDICAL AG
12.2.10 AMERICAN DIAGNOSTIC CORPORATION
12.2.11 NURECA
12.2.12 A&D COMPANY, LIMITED
12.2.13 MEDTRONIC
12.2.14 DONGGUAN ACTHERM MEDICAL CORP.
12.2.15 COSINUSS GMBH
12.2.16 KINSA INC.
12.2.17 EASYTEM
12.2.18 HICKS INDIA
12.2.19 THERMOMEDICS, INC.

13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS